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Introduction: Women with polycystic ovary syndrome (PCOS) are susceptible to 
depression and anxiety, so may also be at risk for postnatal depression (PND). This 
study investigates whether women with PCOS have an elevated risk of PND. 
 
Material and methods: Cross-sectional data for parous women (n=566) were available 
from a birth cohort.  PCOS was diagnosed using the Rotterdam criteria.  Details of 
reproductive history, pregnancy, birth, and PND were obtained through structured 
interview. Comparisons were made between women with and without PCOS using 
logistic regression analysis, including the investigation of interactions. 
 
Results: A positive but statistically non-significant association was found between 
PCOS and PND (OR=1.6, 95% CI 0.9-2.9).  Compared to their counterparts, women 
with PCOS were substantially more likely to have difficulty conceiving (OR=5.2, 
95% CI 2.9-9.4), to have conceived with medical assistance (OR=11.6, 95% CI 5.5-
24.4), and to have pregnancy complications (gestational diabetes, pregnancy-induced 
hypertension, or pre-eclampsia, OR=2.0, 95% CI 1.1-3.5).  Where women with PCOS 
had a history of miscarriage or conceived with medical assistance, the combination 
interacted (p = 0.06 and p < 0.05, respectively), with over half of such women having 
PND. 
 
Conclusions: Whilst women with PCOS may not have an excess risk of PND overall, 
those who had suffered a miscarriage or required medical assistance to conceive were 
at substantially elevated risk. Findings point to vulnerability inherent in PCOS being 
amplified, either by stressful experiences on the pathway to pregnancy/childbirth or 
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Polycystic ovary syndrome 
 
Key message 
As the first study to investigate postnatal depression (PND) risk for women with 
polycystic ovary syndrome, we revealed a substantially greater risk of PND if 







Maternal depression associated with pregnancy and childbirth, known as postnatal 
depression (PND), is a debilitating condition that can have a significant impact on the 
health and wellbeing of the woman, her child and her wider family (1, 2).  PND is 
likely to be under-diagnosed but is estimated to affect 10-20% of mothers in western 
countries (2-4).  
 
Polycystic ovary syndrome (PCOS) is an endocrine disorder, manifesting in 
symptoms that include hirsutism and menstrual irregularity.  Women with PCOS have 
increased susceptibility to depression and anxiety (5), which is an identified risk 
factor for PND (2, 4).  This susceptibility could be due to their perturbed hormonal 
and metabolic profiles, or to distress created by PCOS symptoms and their 
management (6-8).  
 
In addition, women with PCOS often have difficulty conceiving as well as 
complications during pregnancy, which may contribute to stress and dissatisfaction 
and, thereby, to PND (2, 4).  To elaborate, women with PCOS have elevated risk of 
miscarriage, gestational diabetes, pregnancy-induced hypertension and pre-eclampsia 
(9).  Impaired fertility means that women with PCOS are frequently clients of fertility 
clinics (5, 10, 11), a source of stress during treatment (12, 13). Pregnancies achieved 
with medical assistance are, in turn, associated with increased risk of complications 
(14-16). Finally, women with PCOS have relatively more neonates that are preterm or 
small for gestational age, partly due to an excess of twin pregnancies following use of 
ovulation induction drugs (9). 
 
Thus women with PCOS are likely to have a variety of risk factors for PND, including 
a history of depressive symptoms, experience of miscarriage, obstetric and perinatal 
complications, but there has been no investigation of PND in this group to date.  As 
PCOS is the most common endocrine disorder in women of reproductive age (8), 
affecting between 9 and 18% (18), it may contribute to a substantial burden of PND.   
 
We aim to address this gap in knowledge by comparing the occurrence of PND in 
women with and without PCOS in a well characterized community-based sample. We 
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also explore whether prior experiences of difficulty conceiving, medically assisted 
conception, pregnancy complications or suboptimal birth outcomes contribute to any 
increased risk of PND. 
 
 
Materials and methods 
 
This work is based on the first wave of follow up undertaken for a retrospective 
cohort study of women, thus it has a cross-sectional design.  Cohort participants were 
born in 1973-1975 in a large maternity hospital in Adelaide, South Australia.  Around 
30 years later, the 2199 eligible female births were traced.  The 1984 (90.2%) women 
who were confirmed to be living, without any severe impairment, were invited to 
participate by letter and telephone. (For further details of the cohort establishment, see 
(17).) 
 
After acceptance, first wave data were obtained from 947 (49.1%) women at a median 
age of 30.2 years.  Participants were broadly representative of all eligible female 
births, although with a slightly greater proportion of mothers from the highest socio-
economic category (8.8 vs. 5.5%, as derived from postcode of residence (18)).  
Among participants, 568 (60.0%) had given birth to one or more children by the time 
of follow up, and all but two completed questions on PND; these 566 women form the 
current analysis set.  
 
In an appointment with a trained research nurse, women completed a structured 
interview and a series of questionnaires.  Administration was in person for over three 
quarters of women and by telephone for the remainder, principally because they no 
longer resided in Adelaide.  The structured interview covered many aspects of 
women’s lives, symptoms of PCOS, and medical history, including pregnancies.  For 
women seen in person, height and weight were measured following standard 
protocols, otherwise self-reports were obtained.   
 
The Rotterdam criteria were used to identify women with PCOS (19), i.e. a positive 
diagnosis of PCOS required the presence of at least two of the following three 
symptoms: oligo or amenorrhea; clinical and/or biochemical hyperandrogenism; 
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polycystic ovaries. The process of identifying these symptoms has been described in 
detail elsewhere (17). Briefly, women provided details of their menstrual cycle and 
menstrual irregularity was defined as chronic amenorrhea, a cycle length of < 21 or > 
35 days, or variation of > 4 days between cycles.  Women were shown pictures 
representing the modified Ferriman-Gallwey scale which were compared with body 
hair, or reports of the extent prior to removal, to classify hirsutism, with a score of 
more than 7 corresponding to clinical hyperandrogenism.  Women were asked to 
provide a morning blood sample as soon as convenient after the appointment, where 
possible in the follicular phase; free testosterone was used to determine biochemical 
hyperandrogenism.  Women with at least one symptom were offered a transvaginal 
ultrasound to ascertain the presence of polycystic ovaries. 
 
Women who reported a pregnancy of more than 20 weeks were asked whether they 
had experienced depression when pregnant or postnatally.  This was cross-checked 
against another section of the structured interview concerning depression in which 
women provided details of episodes, whether clinically diagnosed, and any treatment.  
The Centre for Epidemiological Studies Depression Scale (CES-D) was also 
completed, with a score of 16 or more indicating current symptoms consistent with 
clinical depression (20, 21). 
 
Women provided a pregnancy history that included miscarriages, premature birth (< 
37 weeks gestation) and multiples.  Women were asked whether they had difficulty 
conceiving and, if so, for details.  These included whether a practitioner of any kind 
was consulted (including alternative medicine) and whether conception occurred with 
medical assistance (including ovulation induction drugs, in vitro fertilization or other 
procedures).  Women reported whether or not they had gestational diabetes, 
pregnancy-induced hypertension, or pre-eclampsia. 
 
At follow up, women reported the highest level of education they had reached and 
whether they were living with a partner at the time of follow up (married or defacto).  
Age at first birth was determined from the dates of birth of the woman and her first 
born child.  Body mass index (BMI), using measured or self-reported height and 
weight, was calculated as weight (kg) divided by the square of height; women were 
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classified as overweight or obese using cut-offs of 25 kg/m2 and 30 kg/m2, 




Almost all variables required for this analysis were categorical so, for simplicity, age 
was classified in five year bands.  There were some missing data items (n=25 for 
BMI, n=41 for CES-D), as women did not have to provide information if they were 
uncomfortable about any question(s). There were two missing values for PND (both 
in women who did not have PCOS), resulting in analyses being based on n=566 
complete cases. 
 
Variables denoting aspects of reproductive history and pregnancy complications were 
considered in the analysis.  It is debatable as to whether these should be treated as 
confounders or as mediators of possible associations between PCOS and PND.  From 
a theoretical perspective, we decided to treat them as mediators with the potential to 
amplify any susceptibility to PND inherent in the women with PCOS.  Socio-
economic status, indicated by educational attainment, is an established independent 
risk factor for PND (4), so it was considered as a potential confounder although we 
did not anticipate it would be influential as the distributions for women with and 
without PCOS had previously been shown to be similar (17). 
 
Descriptive statistics with proportions represented as percentages were generated.  
Logistic regression was undertaken to produce odds ratios and 95% confidence 
intervals for the association between PCOS and PND, as well as between possible 
confounders/mediators and PND.  Logistic regression was also used to assess 
interactions of PCOS status and variables characterizing the course through 
conception-pregnancy-birth in relation to the outcome of PND. 







Study procedures conformed to the principles of the Declaration of Helsinki and 
approval was gained from the institutional review board of the hospital ethics 
committee and the University of Adelaide (H/36/99, March 2000).  All participants 





In the analysis set of parous women, 52 (9.2%) met the Rotterdam criteria for PCOS. 
Three women had menstrual irregularities, hyperandrogenism and PCO; 7 had only 
menstrual irregularities and PCO; 8 had only hyperandrogenism and PCO; 27 had 
menstrual irregularities and hyperandrogenism, and some of these woman may also 
have had PCO as only half of those offered an ultrasound accepted. 
 
Table 1 reports the characteristics of parous women with and without PCOS.  
Compared to other women, those with PCOS were substantially heavier (three in five 
with a BMI meeting the obese classification) and more likely to have depressive 
symptoms (half exceeding the clinical cut off on the CES-D scale) at the time of 
follow up. Women with PCOS were less likely to have completed high school and, 
although the majority were currently living with a partner, the proportion was not as 
high as for their counterparts.  
 
All women in this analysis set had given birth.  The association between PND and 
PCOS was not statistically significant, although the prevalence of PND among 
women with PCOS was observed to be greater than among other women (37% 
compared with 27%), as shown in Table 2. 
 
Also as shown in Table 2, half of women with PCOS reported difficulty conceiving 
and a third had conceived with medical assistance; this was markedly different from 
the reproductive profile of other women as the elevated odds ratios indicate.  During 
pregnancy, women with PCOS were twice as likely as their counterparts to have had 




Figure 1 presents subgroups of women with specific risk factors for PND to depict the 
joint influence of PCOS and each risk factor.  Among women who had experienced 
miscarriage, those with PCOS were more likely to have PND than those without (56% 
vs. 26%, p < 0.05).  Among women who conceived with medical assistance, those 
with PCOS were more likely to have PND than those without (56% vs. 11%, p < 
0.01).  Of note, overlap in the subgroup who had experienced miscarriage and the 
subgroup who had conceived with medical assistance was limited (around 25%).  
Logistic regression analysis formally confirmed a PCOS x miscarriage interaction 
(OR = 3.5, 95% CI 1.0-13.1) and a PCOS x assisted conception interaction (OR = 





In a simple analysis, the association between PCOS and PND was not statistically 
significant, although the data may suggest a positive trend: over one in three parous 
women with PCOS had PND, whereas in women without PCOS the prevalence was 
around one in four.  Reproductive profiles of women with PCOS contrasted with 
those of other women, in terms of difficulty conceiving, mode of conception, 
pregnancy complications and neonatal outcomes, although not all increases in risk 
were statistically significant, particularly where events were less common.  Two 
factors were formally shown to interact with PCOS and elevate PND, a history of 
miscarriage, and requiring medical assistance to conceive.  In both instances, the 
combination of an adverse reproductive exposure and PCOS was associated with 
occurrence of PND in over one in two women. 
 
In agreement with our findings on depressive symptoms at interview, other studies of 
women with PCOS have reported that they have an elevated risk of depression and 
anxiety (5, 6, 22).  While distressing symptoms associated with PCOS may contribute 
to relatively poor mental health profiles (6, 7), a large meta-analysis showed that 
physical symptoms including hirsutism, infertility and obesity did not fully account 
for associations between PCOS and depression, anxiety or emotional distress (22).  
Biochemical characteristics of PCOS were not considered in the meta-analysis and 




Our findings concerning the reproductive profiles of women with PCOS are in 
agreement with those reported previously, including difficulties conceiving (10, 11), 
and requiring medical assistance to conceive (5, 11).  Existing studies have 
demonstrated that women with PCOS have an elevated prevalence of miscarriage (9), 
suggesting that the lack of a statistical significance for some differences observed in 
our study reflects the relatively modest sample size. 
 
The interactions between PCOS and both history of miscarriage and medically 
assisted conception in relation to PND demonstrate the role of the path to 
pregnancy/birth in increased susceptibility to PND.  Patterns in our data suggest that a 
wider range of fertility-related exposures could potentially exacerbate susceptibility, 
but a larger sample would be needed to explore this. 
 
There are several possible explanations for these findings.  One is that the underlying 
endocrine profile of PCOS predisposes some women to PND in addition to 
subfertility.  In women with PCOS, elevated androgens have been shown to be 
associated with negative affect and depressive symptoms (24).  In other women, 
elevated androgens pre- and post-partum have been associated with PND (25), but 
results are inconsistent (26, 27), and the relationship between androgens and mood 
disorders in women remains controversial (20, 29). 
 
It is also possible that a heightened stress response in women with PCOS culminates 
in PND when difficulties with conception/pregnancy are encountered.  Hyper-
responsivity of the hypothalamic-pituitary-adrenal axis has been proposed to 
contribute to poor mental health, including depression, in women with PCOS (30, 31).  
Studies have also shown that, compared to controls matched for age and BMI, women 
with PCOS (without diagnoses of mental disorders) have greater plasma 
adrenocorticotropic hormone and serum cortisol levels following an experimental 
stressor, despite similar levels of emotional distress (reported state anxiety) (30).  
Such hyper-responsivity may mean women with PCOS are less resilient to stress 
caused by infertility, treatment and pregnancy complications.  The possibility that 
interactions between stressful exposures and the endocrine system in PCOS could 
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contribute to a range of symptoms and disorders has been raised by several authors (6, 
22, 32). 
 
Thirdly, it is possible that specific aspects of assisted reproductive treatment 
contribute to PND.  Exposure to ovulation induction during fertility treatment has 
been related to both miscarriage and mood disorders (33, 34).  Women with PCOS are 
sensitive to ovulation induction with regard to the adverse outcome of ovarian 
hyperstimulation syndrome, during which mood disorders are common (34).  
 
This is the first study to specifically investigate the relationship between PCOS and 
PND.  A strength of this study is the use of a community-based sample, thus 
considering a more representative group of women with PCOS than possible with 
clinic-based samples.   
 
This study has several limitations.  A proportion of women with either anovulation or 
hyperandrogenism declined the invitation to have an ultrasound to assess ovaries for 
the presence of cysts.  Consequently there is likely to be a degree of under-
ascertainment of PCOS, with some women in the group without PCOS probably 
misclassified.  This would have a conservative influence on results (i.e. reducing 
observed differences between the groups with and without PCOS).  The analysis 
sample had to comprise parous women, which meant the sample size was relatively 
modest, resulting in some established differences between women with and without 
PCOS (e.g. history of miscarriage) trending in the expected direction but not 
achieving statistical significance.  Alternatively, these may truly be null associations. 
 
Our findings suggest that women with PCOS may be susceptible to PND especially 
when they have reproductive health problems.  We endorse the need for research on 
ovulation stimulation protocols for this patient population to reduce the risk of 
adverse outcomes, as highlighted by others (35).  Given that many women with PCOS 
have contact with health services before conception, there is an opportunity for greater 
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Figure 1.  Prevalence of PND in parous women with and without PCOS, overall, and 
within subgroups based on risk factors for PND; * denotes p < 0.05. 
 
Table 1. Characteristics of parous women at first wave of cohort follow up (n=566) 
 
Table 2. The occurrence of reproductive health problems and pregnancy or birth 





Table 1. Characteristics of parous women at first wave of cohort follow up (n=566) 
Characteristic 
PCOS 
n = 52 
n    (%) 
Without PCOS 
n = 514 
n    (%) 
p -value 
Age (years)       0.81 
< 30 12 (23.1) 111  (21 .6)    
≥ 30 40  (76.9) 403  (78.4)  
BMI (kg/m2), n=541  < 0.01 
Lean or normal (BMI < 25) 12  (24.5) 227  (46.1)  
Overweight (25 ≤ BMI <30) 8  (16.3) 128  (26.0)  
Obese (BMI ≥ 30) 29  (59.2) 137  (27.9)  
Current depression symptoms  
(CES-D > 16), n=525 
22  (47.8) 157  (32.8)   0.04 
Living with a partner 33  (63.5) 389  (75.7)   0.05 
Age at first birth (years)      0.21 
< 25 28  (53.9) 251  (48.8)  
25 - 29 23  (44.2) 217  (42.2)  
≥ 30 1    (1.9) 46    (9.0)  
Children       0.09 
1 25  (48.1) 186  (36.2)  
2+ 27  (51.9) 328  (63.8)  
Educational attainment    0.05 
Some high school 26  (50.0) 192  (37.4)    
Completed high school 15  (28.9) 238  (46.3)  




Table 2 The occurrence  of reproductive health problems and pregnancy or birth complications among parous women with and without PCOS 
(n=566) 
Characteristic 
     PCOS 
     n = 52 
   n     (%) 
 Without PCOS 
     n = 514 




Postnatal depression 19  (36.5) 137  (26.7) 1.6  [0.9-2.9]  
Had difficulty conceiving 27  (51.9) 88  (17.1) 5.2  [2.9-9.4] 
Consulted a practitioner re fertility 21  (40.4) 47    (9.1) 6.7  [3.6-12.6] 
Medical assistance to conceive     16  (30.8) 19    (3.7) 11.6  [5.5-24.4] 
History of miscarriage 16  (30.8) 108  (21.0) 1.7  [0.9-3.1] 
Pregnancy complications 20  (38.5) 125  (24.3) 2.0  [1.1-3.5] 
Preterm birth (<37 weeks) 11  (21.2) 74  (14.4) 1.6  [0.8-3.2] 
Multiple birth 3    (5.8) 19    (3.7) 1.6  [0.5-5.6] 
 
